The right approaches are demonstrating that it is possible to breach the defensively designed blood-brain barrier despite its ...
AviadoBio will combine its proprietary vMiX™ RNAi platform with Apertura’s novel human TfR1 capsid (TfR1 CapX™) to enable one ...
AviadoBio Ltd. ("AviadoBio") and Apertura Gene Therapy ("Apertura"), a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced a licensing ...
In previous work, researchers from CEINGE (Naples, Italy) and collaborating institutions developed an alternative gene therapy strategy based on the expression of a secreted fusion protein, including ...
Multichain biotherapeutics continue to be a promising therapeutic modality. “These therapeutic recombinant proteins are typically assembled from at least three distinct polypeptide chains,” says ...
All aspects of upstream bioprocessing are under pressure to increase expression titers and improve product quality (PQ). To date, major advancements in the glutamine synthetase (GS) system for Chinese ...
Abstract: Orthogonal time frequency space (OTFS) modulation has been shown to support reliable communication in high mobility scenarios. Due to the sparsity of the delay-Doppler (DD) domain, most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results